Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03995017 |
Title | Rucaparib Plus Ramucirumab With or Without Nivolumab in Advanced Gastric and Esophageal Adenocarcinoma (RiME) |
Acronym | RiME |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Anwaar Saeed |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Chicago Medical Center | Chicago | Illinois | 60637 | United States | Details | |
KU Cancer Center | Fairway | Kansas | 66205 | United States | Details | |
University of Kansas Cancer Center - CRC | Fairway | Kansas | 66205 | United States | Details | |
University of Kansas Cancer Center - West | Kansas City | Kansas | 66112 | United States | Details | |
The University of Kansas Cancer Center, Westwood Campus | Kansas City | Kansas | 66205 | United States | Details | |
University of Kansas Cancer Center - Overland Park | Overland Park | Kansas | 66210 | United States | Details | |
University of Kansas Cancer Center - North | Kansas City | Missouri | 64154 | United States | Details | |
University of Kansas Cancer Center - Lee's Summit | Lee's Summit | Missouri | 64064 | United States | Details |